By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Eureka Genomics has netted $3.7 million in financing through a private round that included individuals and undisclosed angel investors.

The Hercules, Calif.-based company said today that it plans to use the funding to advance its studies of novel microorganisms linked to specific cancers and other diseases, and to boost sales and marketing for its high-throughput sequencing data and bioinformatics service businesses.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.